Literature DB >> 16206193

Acute graft-versus-host disease of the heart.

Stephen S Roberts1, Nicky Leeborg, Marc Loriaux, F Leonard Johnson, Meei-Li Huang, Peter Stenzel, Christian Thiede, Kamar T Godder.   

Abstract

Graft-versus-host disease (GVHD) is a frequent cause of morbidity and mortality after bone marrow transplantation. Acute GVHD most commonly involves the skin, gastrointestinal tract, and liver. Involvement of other organ systems is rare and remains controversial. We report a patient with GVHD who suffered a fatal ventricular arrhythmia shortly after bone marrow transplantation. Autopsy of the heart showed lymphocyte infiltration. Investigations for cardiotrophic viruses were negative, and chimerism analysis of the heart showed both donor and recipient DNA. We conclude that the cause of death was possibly graft-versus-host disease of the heart. A review of the literature revealed a total of 14 cases of possible cardiac GVHD. All but one of the reported cases have occurred in pediatric patients and six of those patients died, suggesting that this may be a rare but frequently fatal complication of pediatric allogeneic stem cell transplant. Copyright (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16206193     DOI: 10.1002/pbc.20621

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  2 in total

1.  Dynamics of early histopathological changes in GVHD after busulphan/cyclophosphamide conditioning regimen.

Authors:  Sulaiman Al-Hashmi; Zuzana Hassan; Behnam Sadeghi; Björn Rozell; Moustapha Hassan
Journal:  Int J Clin Exp Pathol       Date:  2011-07-31

2.  Intragraft Molecular Pathways Associated with Tolerance Induction in Renal Transplantation.

Authors:  Lorenzo Gallon; James M Mathew; Sai Vineela Bontha; Catherine I Dumur; Pranav Dalal; Lakshmi Nadimpalli; Daniel G Maluf; Aneesha A Shetty; Suzanne T Ildstad; Joseph R Leventhal; Valeria R Mas
Journal:  J Am Soc Nephrol       Date:  2017-11-30       Impact factor: 10.121

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.